SUMMARY OF COMMON SHARE PURCHASE WARRANT ACTIVITY (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Equity [Abstract] | ||
| Outstanding, beginning of the period | 23,464,096 | 2,126,342 |
| Weighted average exercise price, beginning of the period | $ 9.84 | $ 23.02 |
| Issued | 21,348,826 | |
| Weighted average exercise price, Issued | $ 8.54 | |
| Expired | (301,200) | (11,072) |
| Weighted average exercise price, Expired | $ 28.75 | $ 35.00 |
| Outstanding, end of the period | 23,162,896 | 23,464,096 |
| Weighted average exercise price, end of the period | $ 9.59 | $ 9.84 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|